INOVIO PHARMACEUTICALS, INC. Convertible Debt
INOVIO PHARMACEUTICALS, INC. (INO) had Convertible Debt of $16.30 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2022-11-08
- 2022-09-30: Convertible Debt $16.30M.
- 2022-06-30: Convertible Debt $16.52M.
- 2022-03-31: Convertible Debt $16.21M.
- 2021-12-31: Convertible Debt $14.96M.
| Period end | Convertible Debt |
|---|---|
| 2022-09-30 | $16.30M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $16.52M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.21M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $14.96M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |